What is Dysferlinopathy - Miyoshi Myopathy

Dysferlinopathy - Miyoshi Myopathy is a rare, progressive genetic muscle disorder characterized by the primary wasting and weakness of the calf muscles, caused by a deficiency of the protein dysferlin. It typically manifests in late adolescence or early adulthood and is part of a spectrum of conditions linked to mutations in the DYSF gene.

What is Dysferlinopathy - Miyoshi Myopathy?

Dysferlinopathy - Miyoshi Myopathy is a type of limb-girdle muscular dystrophy (LGMD R2). Unlike many other dystrophies that affect the hips or shoulders first, Dysferlinopathy - Miyoshi Myopathy specifically targets the distal muscles—those furthest from the center of the body—starting with the gastrocnemius (calf) muscles. Over time, the weakness spreads to the thighs, hips, and upper arms.

What causes this condition?

Dysferlinopathy - Miyoshi Myopathy is caused by mutations in the DYSF gene, which provides instructions for making the protein dysferlin. This protein is essential for repairing the membranes of muscle fibers after they are damaged during daily activity. When dysferlin is absent or non-functional, muscle fibers break down more easily, leading to chronic inflammation and muscle wasting.

Who is affected by Dysferlinopathy - Miyoshi Myopathy?

This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene (one from each parent) to develop the disease. While global prevalence is difficult to pinpoint due to underdiagnosis, it is considered a rare disease. Key demographic factors include:

• Age of onset: Symptoms typically emerge between ages 15 and 25.


• Gender: Both males and females are affected equally.


• Clinical presentation: Initial symptoms often include difficulty standing on tiptoes or frequent tripping.


• Community data: Currently, 33 individuals with Dysferlinopathy - Miyoshi Myopathy have shared their experiences on DiseaseMaps.org.

How does it differ from other muscular dystrophies?

The primary differentiator of Dysferlinopathy - Miyoshi Myopathy is the "distal-first" pattern of muscle involvement. While other muscular dystrophies (like Duchenne or Becker) primarily affect the proximal muscles (shoulders and hips) early on, Dysferlinopathy - Miyoshi Myopathy is distinct because it spares these areas until the later stages of the disease.

Next steps

• Consult a neuromuscular specialist or neurologist for a definitive genetic test to confirm a diagnosis.


• Connect with the 33 community members on DiseaseMaps.org to share experiences and coping strategies.


• Inquire about physical therapy programs designed to maintain mobility without overexerting fragile muscle tissue.


• Monitor clinical trials via the NIH or patient foundations for emerging therapies targeting the DYSF gene.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Dysferlinopathy


• Orphanet: Miyoshi Myopathy (ORPHA:612)


• OMIM (Online Mendelian Inheritance in Man): #254130 (Miyoshi Myopathy)


• The Jain Foundation (Specializing in Dysferlinopathy research)